Skip to main content
. 2020 Apr 3;4(5):bvaa039. doi: 10.1210/jendso/bvaa039

Figure 3.

Figure 3.

Event-free survival of patients with and without metastases (95% CI). Comparison of event-free survival (EFS) between patients without metastasis disease at diagnosis (N = 70), and patients with metastasis disease at diagnosis (N = 11). Presence of synchronous metastases at diagnosis was associated with a higher risk of events (P = .004).